ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1474

8-Year Follow-up Study: Differences Between HLA-B27 Positive and Negative Children with Juvenile Idiopathic Arthritis in Finland

Suvi Peltoniemi1, Ellen Berit Nordal2,3, Pekka Lahdenne4 and Kristiina Aalto4, 1Department of Pediatric Rheumatology, Children's Hospital, Helsinki University Hospital, Helsinki, Finland, 2Department of Pediatrics, University Hospital of North Norway, Tromsø, Norway, 3Department of Clinical Medicine, UIT The Arctic University of Norway, Tromsø, Norway, 4Department of Pediatrics, Children's Hospital, Helsinki University Hospital, Helsinki, Finland

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: human leukocyte antigens (HLA) and juvenile idiopathic arthritis (JIA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters. Juvenile Arthritis and Miscellaneous Rheumatic Diseases

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Long-term studies have shown that many patients with juvenile idiopathic arthritis (JIA) still suffer from persistent inflammation and disability as adults. Because of the heterogeneity of JIA, there are not many clinical or laboratory parameters that could be used to clarify the prognosis of a single patient. The human leukocyte antigen HLA-B27 is known to be related to spondyloarthritides in adults. Some children with JIA have the antigen, but at least so far, it has a primary role in the classification. The aim of the study was to find out if there are major differences between HLA-B27 positive and negative children with JIA with respect to disease characteristics during 8-years’ follow-up.

Methods: This study is part of a multicentre population-based cohort study in the Nordic countries based on consecutive patients with a new diagnosis of JIA according to ILAR criteria. They were enrolled 1997-2000 from a defined area of Southern Finland. Information regarding clinical data, serology, and disease activity was registered at certain intervals for 8 years.

Results: 163 of 187 children fulfilled the criteria for 8-year study. HLA-B27 was analysed in 141 patients. 20% of the children were HLA-B27 positive and 67% negative. The most common ILAR categories were enthesitis-related arthritis (41%) among the HLA-B27 positive patients and oligoarthritis (51%) among the negative, when combining the persistent and extended oligoarthritis categories together. At 8-years’ time 41% of the antigen positive patients were not in remission vs. 33% of the antigen negative ones. Also the percentage of current users of biological agents was higher in the HLA-B27 positive group, 28 vs. 18%. The highest incidence of uveitis (30%) was among the HLA-B27 negative patients, who also had the maximum mean number (9) of cumulative joints. A larger proportion of HLA-B27 positive boys with older age at disease onset was found (p=0.004), which is consistent with the findings in other Nordic studies.

Conclusion: Some trends for differences were found regarding the presence of HLA-B27, including the main ILAR subgroups, rates of remission and use of biological agents. However, a statistically significant older age at disease onset was found in HLA-B27 positive boys.


Disclosure: S. Peltoniemi, None; E. B. Nordal, None; P. Lahdenne, None; K. Aalto, None.

To cite this abstract in AMA style:

Peltoniemi S, Nordal EB, Lahdenne P, Aalto K. 8-Year Follow-up Study: Differences Between HLA-B27 Positive and Negative Children with Juvenile Idiopathic Arthritis in Finland [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/8-year-follow-up-study-differences-between-hla-b27-positive-and-negative-children-with-juvenile-idiopathic-arthritis-in-finland/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/8-year-follow-up-study-differences-between-hla-b27-positive-and-negative-children-with-juvenile-idiopathic-arthritis-in-finland/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology